ARAB PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of ADCI for the last quarter is 167.19 M EGP, and it's 24.91% lower compared to the previous quarter. The net income of Q3 24 is 14.52 M EGP.